An Introduction to the Treatment Potential of Cellular Therapy
Cellular therapy is a breakthrough process of treating diseases through integrating new cells into a tissue.
It is done by transplanting a tissue from an organ, fetus, or embryo, which will be injected to recipients with a disease caused by unhealthy tissues and organs.
The new cells are supposed to regenerate damaged tissues and make them function normally once again.
Organs like the adrenals, thyroid and pituitary glands, liver, kidney, ovary and testis, thymus, parotid, spleen, pancreas, heart, and the brain, are usually treated with this kind of therapy.
It is a type of regenerative medicine proven to be effective and even shown to cure a number of hereditary diseases.
Its roots can be traced in 1912, after some physicians treated children with hypothyroid through injecting thyroid cells.
Some say that as early as the 1800s, Dr.
Charles-Edward Brown Sequard used extracts from animal testicle in attempt of stopping the effects of aging among humans.
This was followed by Dr.
Paul Niehans, who developed the therapy and practiced it in Sweden.
He was later deemed as the "Father of Cellular Therapy.
" It is similar to the procedure of bone marrow transplant, where the stem cells in the bone marrow are removed and cleaned, and injected to a person to cure a particular disease like leukemia.
There are two types of cellular therapy, the autologous and allogeneic.
Autologous therapy involves extracting of cells from a patient and then injecting it back to the same patient.
This type of cell transplant is often used as treatment for diseases which require an exact genetic match.
Failure to provide such a compatible sample of cells or tissue can result in severe infection, worsened illness, and even death.
If the patient survives, the incompatible tissue will need to be removed.
The second type is the allogeneic.
Between the two, this is the process most commonly performed.
The stem cell donor may be another person with the same tissue type.
Siblings are often the most ideal donors because tissue types have chances of 25 to 30 percent being alike.
In some cases, these cells are preserved for future doses while some are manufactured.
These manufactured cells can cure up to a hundred patients.
Preserving these cells is the most critical part, as the effectiveness and genetic composition must be retained.
Diseases like stroke, diabetes, and disorders of the nervous system are often cured with this type of therapy.
It is done by transplanting a tissue from an organ, fetus, or embryo, which will be injected to recipients with a disease caused by unhealthy tissues and organs.
The new cells are supposed to regenerate damaged tissues and make them function normally once again.
Organs like the adrenals, thyroid and pituitary glands, liver, kidney, ovary and testis, thymus, parotid, spleen, pancreas, heart, and the brain, are usually treated with this kind of therapy.
It is a type of regenerative medicine proven to be effective and even shown to cure a number of hereditary diseases.
Its roots can be traced in 1912, after some physicians treated children with hypothyroid through injecting thyroid cells.
Some say that as early as the 1800s, Dr.
Charles-Edward Brown Sequard used extracts from animal testicle in attempt of stopping the effects of aging among humans.
This was followed by Dr.
Paul Niehans, who developed the therapy and practiced it in Sweden.
He was later deemed as the "Father of Cellular Therapy.
" It is similar to the procedure of bone marrow transplant, where the stem cells in the bone marrow are removed and cleaned, and injected to a person to cure a particular disease like leukemia.
There are two types of cellular therapy, the autologous and allogeneic.
Autologous therapy involves extracting of cells from a patient and then injecting it back to the same patient.
This type of cell transplant is often used as treatment for diseases which require an exact genetic match.
Failure to provide such a compatible sample of cells or tissue can result in severe infection, worsened illness, and even death.
If the patient survives, the incompatible tissue will need to be removed.
The second type is the allogeneic.
Between the two, this is the process most commonly performed.
The stem cell donor may be another person with the same tissue type.
Siblings are often the most ideal donors because tissue types have chances of 25 to 30 percent being alike.
In some cases, these cells are preserved for future doses while some are manufactured.
These manufactured cells can cure up to a hundred patients.
Preserving these cells is the most critical part, as the effectiveness and genetic composition must be retained.
Diseases like stroke, diabetes, and disorders of the nervous system are often cured with this type of therapy.